HOUSTON, TEXAS August 17, 2010. Pharm-Olam International Ltd. and MB Quest LLC, a member of the Pharm-Olam International Group, a multi-national full service CRO to pharmaceutical and biotech industries announce that MBQ Ukraine was published in the Ukrainian Chamber of Commerce and Industry Catalogue as ranked sixth among 300,000 companies.
The ranking was based on 2009 financial statements submitted to Ukraine statistical authorities which placed MB Quest - Ukraine to be among 10 best Ukrainian companies in main activity category under the Foreign Economic Activity Classifier including companies such as Microsoft and Samsung.
The ranking studied more than 300,000 companies in all sectors of Ukrainian economy using four appraisal criteria including volume of sales, net profit, labor productivity and wage level.
"We have very talented staff in Ukraine to receive such recognition. Data from our studies there has supported successful US NDA approval in infectious disease and urology”, said Eugene Barg, President of MB Quest. “I am proud of our accomplishments in clinical research and business in Ukraine.“
The Pharm-Olam International Group has 27 offices worldwide to assist sponsors in Phase I to Phase IV research. MB Quest which operates in Russia, Ukraine, Georgia, Belarus, and Kazakhstan is a member of the Pharm-Olam International Group.
For further information about conducting trials with Pharm-Olam please contact John Hovre, COO at firstname.lastname@example.org
About Pharm-Olam International Group
Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, POI focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines. Pharm-Olam International Group is organized with operations managed in three Groups – North & South America with headquarters in Houston, Texas, UK & European with headquarters in London, England, and Russia/Ukraine with headquarters in Moscow, Russia.